Other languages Helix BioPharma Corp.

Equities

HBP

CA4229101098

Market Closed - Toronto S.E. Other stock markets 07:36:40 13/05/2024 pm IST			5-day change	1st Jan Change
0.23 ^CAD	0.00%		+4.55%	+9.52%

08/04	Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	CI
28/03	Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary	14/02
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2023	15/12
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2023	28/23/28
Helix BioPharma Corp. to Present New Preclinical Data on L-DOS47 in Combination with PD1 Checkpoint Inhibitor at the 2023 AACR- NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	11/23/11
Helix Biopharma Corp. Announces Board Changes	22/23/22
Helix BioPharma Corp. Announces Executive Changes	22/23/22
Helix BioPharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	15/23/15
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2022	15/22/15
Helix BioPharma Corp. Announces Board Changes	09/22/09
Helix BioPharma Corp. Announces CEO Changes	09/22/09
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2022	01/22/01
Helix BioPharma Corp. Auditor Raises 'Going Concern' Doubt	31/22/31
Helix BioPharma Corp. Appoints Frank Gary Renshaw as Chief Medical Officer	04/22/04
Helix BioPharma Corp. Appoints Gabrielle M Siegers as Head of Research Development Based Out of its Lab in Edmonton	02/22/02
Helix BioPharma Corp. Enters into Two-Year Scientific Collaboration Agreement with University Hospital Tuebingen	09/22/09
Helix BioPharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	15/22/15
Helix BioPharma Corp. Appoints Namrata Malhotra as Corporate Secretary	18/22/18
Helix Biopharma Corp. Appoints Artur Gabor as Chief Executive Officer	18/22/18
Helix Biopharma Corp. Announces Board Changes	18/22/18
Helix Biopharma Corp. Announces Resignation of Krzysztof Saczek from the Board of Directors	07/22/07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Helix BioPharma Corp.

Equities

HBP

CA4229101098

Other languages

Filters